Bal Pharma posts Q3 FY2023 profit at Rs. 59.16 lakhs
The company has reported total income of Rs.77.0791 crores during the period ended December 31, 2022 as compared to Rs.69.9191 crores during the period ended December 31, 2021.
The company has reported total income of Rs.77.0791 crores during the period ended December 31, 2022 as compared to Rs.69.9191 crores during the period ended December 31, 2021.
For discovery or for standardization, Ayurveda colleges/institutes need to collaborate closely with Phytochemists, Pharmacologists, and Toxicologists from premier institutions
With the on-going relentless efforts to imbibe new developments in ART, India will make significant progress in ensuring the best facilities and care for fertility to couples in India
The agreement between Eli Lilly and Janssen was established to allow the two companies to share resources for the goal of accelerating the evaluation of the respective companies’ assets, mirikizumab and Tremfya (guselkumab).
Company has provided Image Transmission and Reporting of Radiology Images and Selective Radiology Services (X-ray Tele Radiology Services) across all districts in the state of Tripura during the month of June, 2022 and operationalized its services at all the allocated places as on date.
The company has reported total income of Rs. 781.40 crores during the period ended December 31, 2022
Theramex were searching for a platform to digitise the manual processes across their R&D landscape
The company has posted net profit of Rs. 475.94 crores for the period ended December 31, 2022
Experts’ conclave to pave holistic approach to cancer management
The company has reported total income of Rs. 1165.31 crores during the period ended December 31, 2022
Subscribe To Our Newsletter & Stay Updated